Cargando…
Antiangiogenic Drug-Induced Proteinuria as a Prognostic Factor in Metastatic Colorectal Cancer
Treatment with bevacizumab is known to cause adverse events such as proteinuria and hypertension, amongst others. However, while bevacizumab-induced hypertension has been linked to increased overall survival (OS), data on proteinuria are controversial. We performed a retrospective analysis to observ...
Autores principales: | Moisuc, Diana Cornelia, Marinca, Mihai Vasile, Gafton, Bogdan, Alexa-Stratulat, Teodora, Pavel-Tanasa, Mariana, Cianga, Petru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221669/ https://www.ncbi.nlm.nih.gov/pubmed/35735428 http://dx.doi.org/10.3390/curroncol29060319 |
Ejemplares similares
-
The Impact of Bevacizumab and Chemotherapy on Quality of Life in Metastatic Colorectal Cancer Patients
por: Moisuc, Diana Cornelia, et al.
Publicado: (2023) -
KRAS, NRAS, BRAF, HER2 and Microsatellite Instability in Metastatic Colorectal Cancer – Practical Implications for the Clinician
por: Afrăsânie, Vlad-Adrian, et al.
Publicado: (2019) -
Can Extended Chemotherapy Improve Glioblastoma Outcomes? A Retrospective Analysis of Survival in Real-World Patients
por: Gherasim-Morogai, Natalia, et al.
Publicado: (2022) -
Oxaliplatin-induced neuropathy and colo-rectal cancer patient’s quality of life: Practical lessons from a prospective cross-sectional, real-world study
por: Prutianu, Iulian, et al.
Publicado: (2022) -
Real Check RIO: A Real-World Analysis of Nivolumab in First Line Metastatic Melanoma Assessing Efficacy, Safety and Predictive Factors
por: Afrăsânie, Vlad-Adrian, et al.
Publicado: (2023)